Intravacc is a renowned, not-for-profit R&D organization for translational vaccinology. The company focus on the development, innovation and optimization of vaccines, vaccine processes and vaccine technologies. The track record includes vaccines as polio, measles, DPT, Hib and Influenza vaccines.
More recently, and as part of the process development and improvement, TFF technologies have received additional attention for purification, concentration, and formulation of enteroviruses vaccine candidates. In this presentation will be explained how Repligen systems have contributed for improved process integration, flexibility, and scale-up.
Leila Dias holds a master degree in Biological Engineering from Lisbon Technical University, and a Professional Doctoral Engineering (PDEng) in Bioprocess Design, from Delft University. She joined Intravacc in 2018 Leila Dias as the Sr DSP scientist in the Process Development of Viral Vaccines. In this role, her focus in on the development and production of innovative vaccines, including virus inactivation, and process optimization, for phase I and II. Her work is strongly driven by quality by design, with an emphasis in process characterization supported by high throughput process development tools, for the fast development of safe, robust and cost effective processes. Prior to this role, through her career she collaborated with several companies and research institutes, including Novartis, Solvay, TNO, DSM, Fujifilm, Synco Biopartners, UniQure and Sanquin in a wide range of biotech projects.